Report Detail

The global drug-eluting balloon market is expected to reach US$ 1,870.60 Mn in 2027 from US$ 516.65 Mn in 2018. The market is estimated to grow with a CAGR of 15.6% from 2019-2027.

The key factors accounting for the growth of market include significant increase in vascular disease incidences, growing product innovations and rising geriatric population. Whereas, the market is expected to have slow growth due to high cost of procedures and products and stringent regulations for approval during the forecast period.

The drug-eluting balloon market comprises various market leaders and emerging players. Medtronic plc, Boston Scientific Corporation, Cook Medical, and Royal Philips (a part of Koninklijke Philips N.V) are among the market leaders, while there are various emerging players operating in the market. These companies are engaged in the constant development of various medical devices. They have developed these products further to ensure their sustenance in the global market. For instance, in November 2019, Medtronic received the US Food and Drug Administration (FDA) approval for its In. Pact AV drug-coated balloon used in the treatment of failing arteriovenous (AV) access in patients suffering from end-stage renal disease (ESRD), undergoing dialysis. Similarly, Royal Philips has launched two new balloons to its Stellarex portfolio of 0.035-inch, low-dose, drug-coated balloons; the additions include 200mm and 150mm Stellarex 0.035-inch low-dose drug-coated balloons. The products have received FDA approval for the treatment of de novo and restenotic lesions in native superficial femoral or popliteal arteries in upper legs.

Such launches of innovative products by market leaders and new players are driving the growth of the drug-eluting balloon market. This is mainly attributed to the fact that these products have expanded treatment options for physicians to treat peripheral artery diseases (PADs), cardiovascular conditions, and renal artery conditions, and so on.

The drug-eluting balloon market is segmented on the basis of product type, and end user. The market based on product type segment is classified as coronary drug eluting balloons, peripheral drug eluting balloons and other product types. Based on end user the market is segmented as hospitals, cath labs & cardiac centers, and ambulatory surgical centers.


TABLE OF CONTENTS

    1. Introduction

    • 1.1 Scope of the Study
    • 1.2 The Insight Partners Research Report Guidance
    • 1.3 Market Segmentation
      • 1.3.1 Global Drug-Eluting Balloon Market - By Product Type
      • 1.3.2 Global Drug-Eluting Balloon Market - By End User
      • 1.3.3 Global Drug-Eluting Balloon Market - By Geography

    2. Drug-Eluting Balloon Market - Key Takeaways

      3. Research Methodology

      • 3.1 Coverage
      • 3.2 Secondary Research
      • 3.3 Primary Research

      4. Drug-Eluting Balloon- Market Landscape

      • 4.1 Overview
      • 4.2 PEST Analysis
        • 4.2.1 North America Drug-Eluting Balloon Market - PEST Analysis
        • 4.2.2 Europe Drug-Eluting Balloon Market- PEST Analysis
        • 4.2.3 Asia Pacific Drug-Eluting Balloon Market - PEST Analysis
        • 4.2.4 Middle East & Africa Drug-Eluting Balloon Market - PEST Analysis
        • 4.2.5 South & Central America Drug-Eluting Balloon Market - PEST Analysis
      • 4.3 Expert Opinion

      5. Drug-Eluting Balloon Market - Key Dynamics

      • 5.1 Key Drivers
        • 5.1.1 Significantly Rising Vascular Disease Incidences
        • 5.1.2 Growing Product Innovations and Launches
        • 5.1.3 Rising Geriatric Population
      • 5.2 Key Restraints
        • 5.2.1 High Cost of Procedures and Products
        • 5.2.2 Stringent Regulations For Approval
      • 5.3 Key Opportunities
        • 5.3.1 Rising Use of Drug-eluting Balloons Over Drug Eluting Stents
      • 5.4 Current Trends
        • 5.4.1 Introduction of DCB Therapy
      • 5.5 Impact Analysis

      6. Drug-Eluting Balloon Market - Global Analysis

      • 6.1 Global Drug-Eluting Balloon Market Revenue Forecast And Analysis
      • 6.2 Global Drug-Eluting Balloon Market, By Geography - Forecast And Analysis
      • 6.3 Positioning Of Key Players

      7. Drug-Eluting Balloon Market Analysis and Forecast to 2027 - Product Type

      • 7.1 Overview
      • 7.2 Global Drug-Eluting Balloon Market, By Product Type, 2018 & 2027 (%)
      • 7.3 Coronary Drug-Eluting Balloons
        • 7.3.1 Overview
        • 7.3.2 Coronary Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
      • 7.4 Peripheral Drug-Eluting Balloons
        • 7.4.1 Overview
        • 7.4.2 Peripheral Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
      • 7.5 Other Product Types
        • 7.5.1 Overview
        • 7.5.2 Other Product Types Market Revenue and Forecast to 2027 (US$ Mn)

      8. Drug-Eluting Balloon Market Analysis and Forecast to 2027 - End User

      • 8.1 Overview
      • 8.2 Global Drug-Eluting Balloon Market, By End User, 2018 & 2027 (%)
      • 8.3 Hospitals
        • 8.3.1 Overview
        • 8.3.2 Hospitals Market Revenue and Forecast to 2027 (US$ Mn)
      • 8.4 Cath Labs and Cardiac Centers
        • 8.4.1 Overview
        • 8.4.2 Cath Labs & Cardiac Centers Market Revenue and Forecast to 2027 (US$ Mn)
      • 8.5 Ambulatory Surgical Centers
        • 8.5.1 Overview
        • 8.5.2 Ambulatory Surgical Centers Market Revenue and Forecast to 2027 (US$ Mn)

      9. Drug-Eluting Balloon Market Revenue And Forecast To 2027 - Geographical Analysis

      • 9.1 North America Drug-Eluting Balloon Market Revenue and Forecast To 2027
        • 9.1.1 Overview
        • 9.1.2 North America Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
        • 9.1.3 North America Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Product Type (US$ Mn)
        • 9.1.4 North America Drug-Eluting Balloon Market Revenue and Forecast To 2027, By End User (US$ Mn)
        • 9.1.5 North America Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Country (%)
        • 9.1.6 US Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
          • 9.1.6.1 US Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
          • 9.1.6.2 US Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Product Type (US$ Mn)
          • 9.1.6.3 US Drug-Eluting Balloon Market Revenue and Forecast to 2027, By End User (US$ Mn)
        • 9.1.7 Canada Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
          • 9.1.7.1 Canada Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
          • 9.1.7.2 Canada Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Product Type (US$ Mn)
          • 9.1.7.3 Canada Drug-Eluting Balloon Market Revenue and Forecast to 2027, By End User (US$ Mn)
        • 9.1.8 Mexico Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
          • 9.1.8.1 Mexico Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
          • 9.1.8.2 Mexico Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Product Type (US$ Mn)
          • 9.1.8.3 Mexico Drug-Eluting Balloon Market Revenue and Forecast to 2027, By End User (US$ Mn)
      • 9.2 Europe Drug-Eluting Balloon Market Revenue and Forecast To 2027
        • 9.2.1 Overview
        • 9.2.2 Europe Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
        • 9.2.3 Europe Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Product Type (US$ Mn)
        • 9.2.4 Europe Drug-Eluting Balloon Market Revenue and Forecast To 2027, By End User (US$ Mn)
        • 9.2.5 Europe Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Country (%)
        • 9.2.6 Germany Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
          • 9.2.6.1 Germany Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
          • 9.2.6.2 Germany Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Product Type (US$ Mn)
          • 9.2.6.3 Germany Drug-Eluting Balloon Market Revenue and Forecast to 2027, By End User (US$ Mn)
        • 9.2.7 UK Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
          • 9.2.7.1 UK Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
          • 9.2.7.2 UK Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Product Type (US$ Mn)
          • 9.2.7.3 UK Drug-Eluting Balloon Market Revenue and Forecast to 2027, By End User (US$ Mn)
        • 9.2.8 France Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
          • 9.2.8.1 France Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
          • 9.2.8.2 France Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Product Type (US$ Mn)
          • 9.2.8.3 France Drug-Eluting Balloon Market Revenue and Forecast to 2027, By End User (US$ Mn)
        • 9.2.9 Spain Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
          • 9.2.9.1 Spain Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
          • 9.2.9.2 Spain Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Product Type (US$ Mn)
          • 9.2.9.3 Spain Drug-Eluting Balloon Market Revenue and Forecast to 2027, By End User (US$ Mn)
        • 9.2.10 Italy Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
          • 9.2.10.1 Italy Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
          • 9.2.10.2 Italy Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Product Type (US$ Mn)
          • 9.2.10.3 Italy Drug-Eluting Balloon Market Revenue and Forecast to 2027, By End User (US$ Mn)
      • 9.3 Asia Pacific Drug-Eluting Balloon Market Revenue and Forecast To 2027
        • 9.3.1 Overview
        • 9.3.2 Asia Pacific Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
        • 9.3.3 Asia Pacific Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Product Type (US$ Mn)
        • 9.3.4 Asia Pacific Drug-Eluting Balloon Market Revenue and Forecast To 2027, By End User (US$ Mn)
        • 9.3.5 Asia Pacific Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Country (%)
        • 9.3.6 China Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
          • 9.3.6.1 China Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
          • 9.3.6.2 China Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Product Type (US$ Mn)
          • 9.3.6.3 China Drug-Eluting Balloon Market Revenue and Forecast to 2027, By End User (US$ Mn)
        • 9.3.7 Japan Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
          • 9.3.7.1 Japan Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
          • 9.3.7.2 Japan Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Product Type (US$ Mn)
          • 9.3.7.3 Japan Drug-Eluting Balloon Market Revenue and Forecast to 2027, By End User (US$ Mn)
        • 9.3.8 India Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
          • 9.3.8.1 India Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
          • 9.3.8.2 India Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Product Type (US$ Mn)
          • 9.3.8.3 India Drug-Eluting Balloon Market Revenue and Forecast to 2027, By End User (US$ Mn)
        • 9.3.9 South Korea Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
          • 9.3.9.1 South Korea Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
          • 9.3.9.2 South Korea Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Product Type (US$ Mn)
          • 9.3.9.3 South Korea Drug-Eluting Balloon Market Revenue and Forecast to 2027, By End User (US$ Mn)
        • 9.3.10 Australia Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
          • 9.3.10.1 Australia Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
          • 9.3.10.2 Australia Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Product Type (US$ Mn)
          • 9.3.10.3 Australia Drug-Eluting Balloon Market Revenue and Forecast to 2027, By End User (US$ Mn)
      • 9.4 Middle East & Africa Drug-Eluting Balloon Market Revenue and Forecast To 2027
        • 9.4.1 Overview
        • 9.4.2 Middle East & Africa Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
        • 9.4.3 Middle East & Africa Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Product Type (US$ Mn)
        • 9.4.4 Middle East & Africa Drug-Eluting Balloon Market Revenue and Forecast To 2027, By End User (US$ Mn)
        • 9.4.5 Middle East & Africa Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Country (%)
        • 9.4.6 Saudi Arabia Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
          • 9.4.6.1 Saudi Arabia Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
          • 9.4.6.2 Saudi Arabia Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Product Type (US$ Mn)
          • 9.4.6.3 Saudi Arabia Drug-Eluting Balloon Market Revenue and Forecast to 2027, By End User (US$ Mn)
        • 9.4.7 UAE Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
          • 9.4.7.1 UAE Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
          • 9.4.7.2 UAE Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Product Type (US$ Mn)
          • 9.4.7.3 UAE Drug-Eluting Balloon Market Revenue and Forecast to 2027, By End User (US$ Mn)
        • 9.4.8 South Africa Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
          • 9.4.8.1 South Africa Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
          • 9.4.8.2 South Africa Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Product Type (US$ Mn)
          • 9.4.8.3 South Africa Drug-Eluting Balloon Market Revenue and Forecast to 2027, By End User (US$ Mn)
      • 9.5 South and Central America Drug-Eluting Balloon Market Revenue and Forecast To 2027
        • 9.5.1 Overview
        • 9.5.2 South and Central America Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
        • 9.5.3 South and Central America Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Product Type (US$ Mn)
        • 9.5.4 South and Central America Drug-Eluting Balloon Market Revenue and Forecast To 2027, By End User (US$ Mn)
        • 9.5.5 South and Central America Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Country (%)
        • 9.5.6 Brazil Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
          • 9.5.6.1 Brazil Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
          • 9.5.6.2 Brazil Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Product Type (US$ Mn)
          • 9.5.6.3 Brazil Drug-Eluting Balloon Market Revenue and Forecast to 2027, By End User (US$ Mn)
        • 9.5.7 Argentina Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
          • 9.5.7.1 Argentina Drug-Eluting Balloon Market Revenue and Forecast to 2027 (US$ Mn)
          • 9.5.7.2 Argentina Drug-Eluting Balloon Market Revenue and Forecast to 2027, By Product Type (US$ Mn)
          • 9.5.7.3 Argentina Drug-Eluting Balloon Market Revenue and Forecast to 2027, By End User (US$ Mn)

        10. Drug-Eluting Balloon Market Industry Landscape

        • 10.1 Overview
        • 10.2 Growth Strategies In The Drug-Eluting Balloon Market, 2016-2019
        • 10.3 Developments
          • 10.3.1 Overview
          • 10.3.2 Growth Strategies In The Drug-Eluting Balloon Market, 2016-2019

        11. Drug-Eluting Balloon Market-Key Company Profiles

        • 11.1 Koninklijke Philips N.V.
          • 11.1.1 Key Facts
          • 11.1.2 Business Description
          • 11.1.3 Financial Overview
          • 11.1.4 Product Portfolio
          • 11.1.5 SWOT Analysis
          • 11.1.6 Key Developments
        • 11.2 Concept Medical Inc.
          • 11.2.1 Key Facts
          • 11.2.2 Business Description
          • 11.2.3 Financial Overview
          • 11.2.4 Product Portfolio
          • 11.2.5 SWOT Analysis
          • 11.2.6 Key Developments
        • 11.3 Opto Circuits (India) Limited (Eurocor Tech GmbH)
          • 11.3.1 Key Facts
          • 11.3.2 Business Description
          • 11.3.3 Financial Overview
          • 11.3.4 Product Portfolio
          • 11.3.5 SWOT Analysis
          • 11.3.6 Key Developments
        • 11.4 Terumo Corporation
          • 11.4.1 Key Facts
          • 11.4.2 Business Description
          • 11.4.3 Financial Overview
          • 11.4.4 Product Portfolio
          • 11.4.5 SWOT Analysis
          • 11.4.6 Key Developments
        • 11.5 BIOTRONIK SE & Co. KG
          • 11.5.1 Key Facts
          • 11.5.2 Business Description
          • 11.5.3 Financial Overview
          • 11.5.4 Product Portfolio
          • 11.5.5 SWOT Analysis
          • 11.5.6 Key Developments
        • 11.6 Innvolution Healthcare Pvt. Ltd.
          • 11.6.1 Key Facts
          • 11.6.2 Business Description
          • 11.6.3 Financial Overview
          • 11.6.4 Product Portfolio
          • 11.6.5 SWOT Analysis
          • 11.6.6 Key Developments
        • 11.7 Medtronic Plc
          • 11.7.1 Key Facts
          • 11.7.2 Business Description
          • 11.7.3 Financial Overview
          • 11.7.4 Product Portfolio
          • 11.7.5 SWOT Analysis
          • 11.7.6 Key Developments
        • 11.8 BD
          • 11.8.1 Key Facts
          • 11.8.2 Business Description
          • 11.8.3 Financial Overview
          • 11.8.4 Product Portfolio
          • 11.8.5 SWOT Analysis
          • 11.8.6 Key Developments
        • 11.9 Boston Scientific Corporation
          • 11.9.1 Key Facts
          • 11.9.2 Business Description
          • 11.9.3 Financial Overview
          • 11.9.4 Product Portfolio
          • 11.9.5 SWOT Analysis
          • 11.9.6 Key Developments
        • 11.10 Cook Medical
          • 11.10.1 Key Facts
          • 11.10.2 Business Description
          • 11.10.3 Financial Overview
          • 11.10.4 Product Portfolio
          • 11.10.5 SWOT Analysis
          • 11.10.6 Key Developments
        • 11.11 B. Braun Melsungen AG
          • 11.11.1 Key Facts
          • 11.11.2 Business Description
          • 11.11.3 Financial Overview
          • 11.11.4 Product Portfolio
          • 11.11.5 SWOT Analysis
          • 11.11.6 Key Developments

        12. Appendix

        • 12.1 About The Insight Partners
        • 12.2 Glossary of Terms

      Summary:
      Get latest Market Research Reports on Drug-Eluting Balloon . Industry analysis & Market Report on Drug-Eluting Balloon is a syndicated market report, published as Drug-Eluting Balloon Market to 2027 - Global Analysis and Forecasts by Product Type (Coronary Drug Eluting Balloons, Peripheral Drug Eluting Balloons and Other Product Types); End User (Hospitals, Cath Labs & Cardiac Centers, and Ambulatory Surgical Centers), and Geography. It is complete Research Study and Industry Analysis of Drug-Eluting Balloon market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $4,550.00
      $6,550.00
      $8,550.00
      3,640.00
      5,240.00
      6,840.00
      4,249.70
      6,117.70
      7,985.70
      718,627.00
      1,034,507.00
      1,350,387.00
      379,606.50
      546,466.50
      713,326.50
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report